# Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)

> **NCT04322123** · PHASE3 · COMPLETED · sponsor: **Hospital do Coracao** · enrollment: 667 (actual)

## Conditions studied

- Coronavirus Infections

## Interventions

- **DRUG:** Hydroxychloroquine Oral Product
- **DRUG:** Hydroxychloroquine + azithromycin

## Key facts

- **NCT ID:** NCT04322123
- **Lead sponsor:** Hospital do Coracao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-06-02
- **Final completion:** 2020-06-02
- **Target enrollment:** 667 (ACTUAL)
- **Last updated:** 2022-04-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322123, "Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04322123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*